Previous studies have demonstrated the existence of a circulating myocardial depressant
substance during human septic shock. We have recently identified this substance as a …

1. Bruneau J, Ahamad K, Goyer M-È, et al. Management of opioid use disorders: a national
clinical practice guideline. CMAJ 2018; 190: E247-57. 2. McClain DA, Hug CC Jr. …

“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing
during the pandemic documented through an environmental scan of addiction and harm …

Introduction and Aims Buprenorphine/naloxone is an evidence‐based treatment for opioid
use disorder, but an identified limitation is the period of required opioid abstinence prior to …

Medicinal and recreational Cannabis sativa is a sector that has exploded in popularity both
in academia and industry due to the relaxation in legislation concerning the controlled …

Introduction and Aims North America is currently experiencing an epidemic of opioid
overdose deaths, driven by the proliferation of fentanyl in the street drug market. Although …

Background Long-term engagement in opioid agonist therapy (OAT) has been consistently
associated with reduced risk for morbidity and mortality in people with opioid use disorder (…

Across North America, overlapping overdose and COVID-19 emergencies have had a substantial
impact on young people who use drugs (YPWUD). New risk mitigation guidance (RMG…

To date, over 4 million people globally have been infected with severe acute respiratory
syndrome coronavirus 2 (SARSCoV2), resulting in more than 250 000 deaths. 1 Populations at …

Objectives: Ever since the discovery of Mycobacterium tuberculosis in 1882, many
diagnostic methods have been developed. However" The gold standard" for the diagnosis of …